Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1α

Cell

Volumn 122, Issue 4, 2005, Pages 505-515

  Handschin, Christoph ^a   Lin, Jiandie ^a   Rhee, James ^a   Peyer, Anne Kathrin ^b   Chin, Sherry ^a   Wu, Pei Hsuan ^a   Meyer, Urs A ^b   Spiegelman, Bruce M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 2,4,6 TRIMETHYL 3,5 PYRIDINEDICARBOXYLIC ACID DIETHYL ESTER; 5 AMINOLEVULINATE SYNTHASE; ADENOVIRUS VECTOR; HEME; LEAD;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; ENZYME INDUCTION; HEME SYNTHESIS; IN VIVO STUDY; KNOCKOUT MOUSE; LIVER METABOLISM; MOUSE; NONHUMAN; NUTRITION; NUTRITIONAL STATUS; PORPHYRIA; PRIORITY JOURNAL; REGULATORY MECHANISM;

ANIMALIA;

EID: 23944476164     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2005.06.040     Document Type: Article

References (43)

1. H.L. Bonkovsky, E.E. Cable, J.W. Cable, S.E. Donohue, E.C. White, Y.J. Greene, R.W. Lambrecht, K.K. Srivastava, and W.N. Arnold Porphyrogenic properties of the terpenes camphor, pinene, and thujone (with a note on historic implications for absinthe and the illness of Vincent van Gogh) Biochem. Pharmacol. 43 1992 2359 2368
2. G. Braidotti, I.A. Borthwick, and B.K. May Identification of regulatory sequences in the gene for 5-aminolevulinate synthase from rat J. Biol. Chem. 268 1993 1109 1117
3. A. Brunet, A. Bonni, M.J. Zigmond, M.Z. Lin, P. Juo, L.S. Hu, M.J. Anderson, K.C. Arden, J. Blenis, and M.E. Greenberg Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor Cell 96 1999 857 868
4. E.T. Canepa, E.B. Llambias, and M. Grinstein Effect of glucose on the induction of delta-aminolevulinic acid synthase and ferrochelatase in isolated rat hepatocytes by allylisopropylacetamide Biochim. Biophys. Acta 804 1984 8 15
5. J.R. Davis, and S.L. Andelman Urinary delta-aminolevulinic acid (ALA) levels in lead poisoning. I. A modified method for the rapid determination of urinary delta-aminolevulinic acid using disposable ion-exchange chromatography columns Arch. Environ. Health 15 1967 53 59
6. F. De Matteis Drug interactions in experimental hepatic porphyria. A model for the exacerbation by drugs of human variegate porphyria Enzyme 16 1973 266 275
7. F. De Matteis, G. Abbritti, and A.H. Gibbs Decreased liver activity of porphyrin-metal chelatase in hepatic porphyria caused by 3,5-diethoxycarbonyl-1, 4-dihydrocollidine. Studies in rats and mice Biochem. J. 134 1973 717 727
8. G.H. Elder Genetic defects in the porphyrias: types and significance Clin. Dermatol. 16 1998 225 233
9. G.H. Elder, R.J. Hift, and P.N. Meissner The acute porphyrias Lancet 349 1997 1613 1617
10. D.J. Fraser, M. Podvinec, M.R. Kaufmann, and U.A. Meyer Drugs mediate the transcriptional activation of the 5-aminolevulinic acid synthase (ALAS1) gene via the chicken xenobiotic-sensing nuclear receptor (CXR) J. Biol. Chem. 277 2002 34717 34726
11. D.J. Fraser, A. Zumsteg, and U.A. Meyer Nuclear receptors constitutive androstane receptor and pregnane X receptor activate a drug-responsive enhancer of the murine 5-aminolevulinic acid synthase gene J. Biol. Chem. 278 2003 39392 39401
12. U. Giger, and U.A. Meyer Induction of delta-aminolevulinate synthase and cytochrome P-450 hemoproteins in hepatocyte culture. Effect of glucose and hormones J. Biol. Chem. 256 1981 11182 11190
13. C. Handschin, J. Rhee, J. Lin, P.T. Tarr, and B.M. Spiegelman An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle Proc. Natl. Acad. Sci. USA 100 2003 7111 7116
14. S. Herzig, F. Long, U.S. Jhala, S. Hedrick, R. Quinn, A. Bauer, D. Rudolph, G. Schutz, C. Yoon, and P. Puigserver CREB regulates hepatic gluconeogenesis through the coactivator PGC-1 Nature 413 2001 179 183
15. J.A. Iniguez-Lluhi, D.Y. Lou, and K.R. Yamamoto Three amino acid substitutions selectively disrupt the activation but not the repression function of the glucocorticoid receptor N terminus J. Biol. Chem. 272 1997 4149 4156
16. A. Kappas, S. Sassa, R.A. Galbraith, and Y. Nordmann The Porphyrias Seventh Edition 1995 McGraw-Hill New York
17. T. Kawaguchi, K. Osatomi, H. Yamashita, T. Kabashima, and K. Uyeda Mechanism for fatty acid "sparing" effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase J. Biol. Chem. 277 2002 3829 3835
18. J.J. Lehman, P.M. Barger, A. Kovacs, J.E. Saffitz, D.M. Medeiros, and D.P. Kelly Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis J. Clin. Invest. 106 2000 847 856
19. J. Lin, P.H. Wu, P.T. Tarr, K.S. Lindenberg, J. St-Pierre, C.Y. Zhang, V.K. Mootha, S. Jager, C.R. Vianna, and R.M. Reznick Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice Cell 119 2004 121 135
20. R.L. Lindberg, C. Porcher, B. Grandchamp, B. Ledermann, K. Burki, S. Brandner, A. Aguzzi, and U.A. Meyer Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria Nat. Genet. 12 1996 195 199
21. R.L. Lindberg, R. Martini, M. Baumgartner, B. Erne, J. Borg, J. Zielasek, K. Ricker, A. Steck, K.V. Toyka, and U.A. Meyer Motor neuropathy in porphobilinogen deaminase-deficient mice imitates the peripheral neuropathy of human acute porphyria J. Clin. Invest. 103 1999 1127 1134
22. L.S. Loftus, and W.N. Arnold Vincent van Gogh's illness: acute intermittent porphyria? BMJ 303 1991 1589 1591
23. I. Macalpine, and R. Hunter The "insanity" of King George 3d: a classic case of porphyria BMJ 5479 1966 65 71
24. I. Macalpine, R. Hunter, and C. Rimington Porphyria in the royal houses of Stuart, Hanover, and Prussia. A follow-up study of George 3d's illness BMJ 1 1968 7 18
25. B.K. May, S.C. Dogra, T.J. Sadlon, C.R. Bhasker, T.C. Cox, and S.S. Bottomley Molecular regulation of heme biosynthesis in higher vertebrates Prog. Nucleic Acid Res. Mol. Biol. 51 1995 1 51
26. M. Mendez, V. Parera, R. Enriquez de Salamanca, and A. Batlle Amiodarone is a pharmacologically safe drug for porphyrias Gen. Pharmacol. 32 1999 259 263
27. J. Nakae, T. Kitamura, D.L. Silver, and D. Accili The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression J. Clin. Invest. 108 2001 1359 1367
28. C.A. Pierach, and E. Jennewein Friedrich Wilhelm I and porphyria Sudhoffs Arch. Z. Wissenschaftsgesch. 83 1999 50 66
29. M. Podvinec, C. Handschin, R. Looser, and U.A. Meyer Identification of the xenosensors regulating human 5-aminolevulinate synthase Proc. Natl. Acad. Sci. USA 101 2004 9127 9132
30. P. Puigserver, and B.M. Spiegelman Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha): transcriptional coactivator and metabolic regulator Endocr. Rev. 24 2003 78 90
31. P. Puigserver, Z. Wu, C.W. Park, R. Graves, M. Wright, and B.M. Spiegelman A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis Cell 92 1998 829 839
32. P. Puigserver, J. Rhee, J. Donovan, C.J. Walkey, J.C. Yoon, F. Oriente, Y. Kitamura, J. Altomonte, H. Dong, D. Accili, and B.M. Spiegelman Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction Nature 423 2003 550 555
33. Robert, T.L., Varella, L., and Meguid, M.M. (1994). Nutrition management of acute intermittent porphyria. Nutrition 10, 551-555; quiz 556-557.
34. M.E. Scassa, C.L. Varone, L. Montero, and E.T. Canepa Insulin inhibits delta-aminolevulinate synthase gene expression in rat hepatocytes and human hepatoma cells Exp. Cell Res. 244 1998 460 469
35. M.E. Scassa, A.S. Guberman, C.L. Varone, and E.T. Canepa Phosphatidylinositol 3-kinase and Ras/mitogen-activated protein kinase signaling pathways are required for the regulation of 5-aminolevulinate synthase gene expression by insulin Exp. Cell Res. 271 2001 201 213
36. M.E. Scassa, A.S. Guberman, J.M. Ceruti, and E.T. Canepa Hepatic nuclear factor 3 and nuclear factor 1 regulate 5-aminolevulinate synthase gene expression and are involved in insulin repression J. Biol. Chem. 279 2004 28082 28092
37. H. Thadani, A. Deacon, and T. Peters Diagnosis and management of porphyria BMJ 320 2000 1647 1651
38. S. Thunell Porphyrins, porphyrin metabolism and porphyrias. I. Update Scand. J. Clin. Lab. Invest. 60 2000 509 540
39. C.L. Varone, L.E. Giono, A. Ochoa, M.M. Zakin, and E.T. Canepa Transcriptional regulation of 5-aminolevulinate synthase by phenobarbital and cAMP-dependent protein kinase Arch. Biochem. Biophys. 372 1999 261 270
40. J.V. Virbasius, and R.C. Scarpulla Activation of the human mitochondrial transcription factor A gene by nuclear respiratory factors: a potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis Proc. Natl. Acad. Sci. USA 91 1994 1309 1313
41. Z. Wu, P. Puigserver, U. Andersson, C. Zhang, G. Adelmant, V. Mootha, A. Troy, S. Cinti, B. Lowell, R.C. Scarpulla, and B.M. Spiegelman Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1 Cell 98 1999 115 124
42. H. Yamashita, M. Takenoshita, M. Sakurai, R.K. Bruick, W.J. Henzel, W. Shillinglaw, D. Arnot, and K. Uyeda A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver Proc. Natl. Acad. Sci. USA 98 2001 9116 9121
43. J.C. Yoon, P. Puigserver, G. Chen, J. Donovan, Z. Wu, J. Rhee, G. Adelmant, J. Stafford, C.R. Kahn, and D.K. Granner Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1 Nature 413 2001 131 138